Histone Deacetylase Inhibitors as Cancer Therapeutics, Vol 116. Advances in Cancer Research

  • ID: 2484188
  • Book
  • 288 Pages
  • Elsevier Science and Technology
1 of 3

Advances in Cancer Research provides invaluable information on the exciting and fast-moving field of cancer research. This thematic volume looks at "Histone Deacetylase Inhibitors as Cancer Therapeutics."

  • Provides invaluable information on the exciting and fast-moving field of cancer research
  • This thematic volume looks at "Histone Deacetylase Inhibitors as Cancer Therapeutics"
  • Outstanding and original reviews
Note: Product cover images may vary from those shown
2 of 3
- Histone Deacetylase Inhibitors Disrupt the Mitotic Spindle Assembly Checkpoint by Targeting Histone and Non-Histone Proteins - Mechanisms of Resistance to Histone Deacetylase Inhibitors - HDAC Inhibitors: Roles of DNA Damage and Repair - HDAC Inhibitor Modulation of Proteotoxicity as a Therapeutic Approach in Cancer - Intrinsic and Extrinsic Apoptotic Pathway Signaling as Determinants of Histone Deacetylase Inhibitor Anti-Tumor Activity - Histone Deacetylase Inhibitors and Rational Combination Therapies - HDAC Inhibitors and Chaperone Function
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll